BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 12381485)

  • 1. Villoglandular papillary adenocarcinoma of the uterine cervix with bulky lymph node metastases.
    Utsugi K; Shimizu Y; Akiyama F; Hasumi K
    Eur J Obstet Gynecol Reprod Biol; 2002 Nov; 105(2):186-8. PubMed ID: 12381485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathologic features of villoglandular papillary adenocarcinoma of the uterine cervix.
    Utsugi K; Shimizu Y; Akiyama F; Umezawa S; Hasumi K
    Gynecol Oncol; 2004 Jan; 92(1):64-70. PubMed ID: 14751140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of villoglandular papillary adenocarcinoma of the cervix with lymph node metastasis.
    Garcea A; Nunns D; Ireland D; Brown L
    BJOG; 2003 Jun; 110(6):627-9. PubMed ID: 12798484
    [No Abstract]   [Full Text] [Related]  

  • 4. Well-differentiated papillary villoglandular adenocarcinoma of the uterine cervix.
    Datta CK
    W V Med J; 1997; 93(4):186-8. PubMed ID: 9274143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Villoglandular papillary adenocarcinoma of the uterine cervix responding to neoadjuvant chemotherapy with docetaxel and cisplatin: a case report.
    Nagai N; Hirata E; Kusuda T; Mukai K; Arihiro K; Ohama K
    Int J Gynecol Cancer; 2005; 15(6):1187-90. PubMed ID: 16343210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conservative management for villoglandular papillary adenocarcinoma of the cervix diagnosed during pregnancy followed by a successful term delivery: a case report and a review of the literature.
    Lavie O; Segev Y; Peer G; Gutterman E; Sagie S; Auslnader R
    Eur J Surg Oncol; 2008 May; 34(5):606-8. PubMed ID: 17643913
    [No Abstract]   [Full Text] [Related]  

  • 7. Villoglandular papillary adenocarcinoma of the uterine cervix with immunohistochemical characteristics.
    Polat A; Düsmez D; Pata O; Aydin O; Egilmez R
    J Exp Clin Cancer Res; 2002 Sep; 21(3):425-7. PubMed ID: 12385589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The rule of metastatic pelvic lymph node distribution in patients with early stage cervical carcinoma].
    Zhang HY; Sheng XG; Zhong Y; Ma ZF; Ma YB; Liu NF; Chen YT; Wang YY
    Zhonghua Zhong Liu Za Zhi; 2008 Jun; 30(6):452-5. PubMed ID: 19024522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Well-Differentiated villoglandular adenocarcinoma of the uterine cervix: a report of 15 cases including two with lymph node metastasis.
    Khunamornpong S; Maleemonkol S; Siriaunkgul S; Pantusart A
    J Med Assoc Thai; 2001 Jun; 84(6):882-8. PubMed ID: 11556470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Villoglandular papillary adenocarcinoma of the cervix: a series of 28 cases including two with lymph node metastasis.
    Lataifeh IM; Al-Hussaini M; Uzan C; Jaradat I; Duvillard P; Morice P
    Int J Gynecol Cancer; 2013 Jun; 23(5):900-5. PubMed ID: 23552807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Risk factors and prognosis of node-positive cervical carcinoma].
    Feng SY; Zhang YN; Liu JG
    Ai Zheng; 2005 Oct; 24(10):1261-6. PubMed ID: 16219145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cervical adenocarcinoma: histologic staging and pelvic lymph node metastasis].
    Sakamoto A; Kitagawa T; Sugano H
    Gan No Rinsho; 1984 Feb; 30(2):138-44. PubMed ID: 6708302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolated para-aortic lymph node metastasis in FIGO stage IA2-IB2 carcinoma of the cervix: Revisiting the role of surgical assessment.
    Del Carmen MG; Pareja R; Melamed A; Rodriguez J; Greer A; Clark RM; Rice LW
    Gynecol Oncol; 2018 Sep; 150(3):406-411. PubMed ID: 30017539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality and quantity metrics of pelvic lymph node metastasis and risk of para-aortic lymph node metastasis in stage IB-IIB cervical cancer.
    Matsuo K; Grubbs BH; Mikami M
    J Gynecol Oncol; 2018 Jan; 29(1):e10. PubMed ID: 29185268
    [No Abstract]   [Full Text] [Related]  

  • 15. Can pelvic lymphadenectomy be omitted in stage IA2 to IIB uterine cervical cancer?
    Togami S; Kamio M; Yanazume S; Yoshinaga M; Douchi T
    Int J Gynecol Cancer; 2014 Jul; 24(6):1072-6. PubMed ID: 24905616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Villous glandular adenocarcinoma of the uterine cervix. A subtype with favourable prognosis?].
    Reed W; Abeler VM; Tropé CG
    Tidsskr Nor Laegeforen; 1993 Aug; 113(20):2569-71. PubMed ID: 8236177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical analysis of the recurrence of early stage bulky cervical carcinoma].
    Hu JL; Wu LY; Li XG; Zhang R; Li N; Yao HW
    Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):378-81. PubMed ID: 22883461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sentinel lymphatic mapping among women with early-stage cervical cancer: A systematic review.
    Cheng-Yen Lai J; Lai KJ; Yi-Yung Yu E; Hung ST; Chu CY; Wang KL
    Taiwan J Obstet Gynecol; 2018 Oct; 57(5):636-643. PubMed ID: 30342642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microinvasive cervical adenocarcinoma (FIGO stage 1A tumors): results of surgical staging and outcome analysis.
    Ceballos KM; Shaw D; Daya D
    Am J Surg Pathol; 2006 Mar; 30(3):370-4. PubMed ID: 16538058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multivariate analysis of histopathologic prognostic factors for invasive cervical cancer treated with radical hysterectomy and systematic retroperitoneal lymphadenectomy.
    Takeda N; Sakuragi N; Takeda M; Okamoto K; Kuwabara M; Negishi H; Oikawa M; Yamamoto R; Yamada H; Fujimoto S
    Acta Obstet Gynecol Scand; 2002 Dec; 81(12):1144-51. PubMed ID: 12519111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.